Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Medicate Sweden AB
AB
Active
Org 5594445123
Stenkällevägen 41
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2023
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 0
EBITDA margin
—
Equity ratio
100.4%
Financial strength
Net profit 2024
SEK -28K
0 employees
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2024
Key figures
Annual report 2024
Revenue
SEK 0
—
EBITDA
SEK -29K
—
Net profit
SEK -28K
—
Total assets
SEK 29K
—
Equity
SEK 29K
—
Employees
0
—
Company information
Legal name
Medicate Sweden AB
Org number
5594445123
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
15 augusti 2023
Share capital
SEK 25 200
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall idka handel med produkter och material för hälso och sjukvårdsbranschen samt annan därmed förenlig verksamhet.
Contact
Address
Stenkällevägen 41
Email
sam@medicatesweden.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Malmö
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2024
Income statement
SEK thousands
Item
2024
Revenue
0
Staff expenses
−0
EBITDA
−29
Depreciation & amort.
—
EBIT
−29
Net financials
1
Profit before tax
−28
Tax
—
Net profit
−28
Balance sheet
SEK thousands
Item
2024
Total assets
29
Equity
29
Long-term debt
0
Short-term debt
−0
Total debt
−0
Financial ratios
5-year trend
EBITDA margin
-2887000.0%
This company
15.8%
Market median
-18272252% vs market
2024
2024
Equity ratio
100.4%
This company
38.2%
Market median
+163% vs market
2024
2024
Return on equity
-96.3%
This company
18.4%
Market median
-623% vs market
2024
2024
Net profit margin
-2788000.0%
This company
8.1%
Market median
-34419853% vs market
2024
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2024
2024
Debt / equity
-0.00×
This company
0.62×
Market median
+100% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-08-15 – 2024-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
HN
Hedeel Nassir Hussain
Deputy Board Member
2023
SM
Sam Mohammed Mahdi
Board of Directors
2023
Former (4)
AA
Alaa Abbas
Chairman
2023 – 2025
NA
Nada Abbas
Deputy Board Member
2023 – 2025
OA
Oday Almuhamadi
Board of Directors
2023 – 2025
ZN
Zahra Nouri Mahdi
Deputy Board Member
2023 – 2025
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Medicate Sweden AB also hold positions in
0
other companies.
Person
Role here
Other companies
Hedeel Nassir Hussain
Deputy Board Member
0 companies
Alaa Abbas
Chairman
0 companies
Nada Abbas
Deputy Board Member
0 companies
Sam Mohammed Mahdi
Board of Directors
0 companies
Oday Almuhamadi
Board of Directors
0 companies
Zahra Nouri Mahdi
Deputy Board Member
0 companies